(Adds quote)
BRUSSELS, Nov 16 (Reuters) - The European Commission will
authorise a deal with German biotech firm CureVac on
Tuesday to secure up to 405 million doses of its potential
COVID-19 vaccine, the head of the European Commission, Ursula
von der Leyen, said.
"I am happy to announce a new agreement. Tomorrow will
authorise a new contract to secure another COVID-19 vaccine for
Europeans," she said, adding that the contract with the German
firm follows EU funding to the company to develop its vaccine.
The Commission president also said she hoped to finalise a
deal soon with Moderna for its COVID-19 vaccine.
The deal with CureVac follows supply agreements the
Commission has reached with AstraZeneca, Johnson &
Johnson, Sanofi, and Pfizer for the
supply of their potential vaccines.
(Reporting by Francesco Guarascio @fraguarascio; Editing by
Nick Macfie)
Astrazeneca (AZN)
